Journal update monthly top five
The St. Vincent's Emergency Research Group has curated a set of five external papers for consensus review, highlighting key literature relevant to emergency medicine practice. Of these, the TRACE-5 trial stands out as a 'game changer,' focusing on tenecteplase versus standard care for basilar artery occlusion within 24 hours. Basilar artery occlusion represents a severe posterior circulation stroke with high associated morbidity and mortality. The findings from this multicenter, prospective, randomized, open-label, blinded-endpoint trial suggest significant potential shifts in how we manage reperfusion therapy for these challenging strokes.
The St. Vincent's Emergency Research Group has curated a set of five external papers for consensus review, highlighting key literature relevant to emergency medicine practice. Of these, the TRACE-5 trial stands out as a 'game changer,' focusing on tenecteplase versus standard care for basilar artery occlusion within 24 hours. Basilar artery occlusion represents a severe posterior circulation stroke with high associated morbidity and mortality. The findings from this multicenter, prospective, randomized, open-label, blinded-endpoint trial suggest significant potential shifts in how we manage reperfusion therapy for these challenging strokes.
Show moreShow less
Given the 'game changer' rating, you should pay close attention to the TRACE-5 data regarding tenecteplase use for basilar artery occlusion within 24 hours. While this suggests a potential shift in standard care, remember that consensus is key; review the full paper to understand its specific inclusion criteria and limitations before making any immediate protocol changes at the bedside.